Company Filing History:
Years Active: 2021-2024
Title: Megumi Maruyama: Innovator in Modified Release Formulations
Introduction
Megumi Maruyama is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release formulations. With a total of three patents to her name, her work has the potential to impact the treatment of various diseases and disorders.
Latest Patents
Her latest patents focus on modified release compositions in solid oral dosage forms comprising amisulpride. These formulations utilize an unequal mixture of (R)-amisulpride and (S)-amisulpride, where the amount of (R)-amisulpride exceeds that of (S)-amisulpride. The patents also cover the use of pharmaceutically acceptable salts of amisulpride and methods for treating various diseases and disorders, including specific dosage regimens. Additionally, her work includes formulations that employ polymorphs of enantiomeric amisulpride.
Career Highlights
Megumi Maruyama is currently associated with Sunovion Pharmaceuticals Inc., where she continues to innovate in the pharmaceutical sector. Her expertise in modified release formulations has positioned her as a key player in the industry.
Collaborations
She has collaborated with notable coworkers, including Takumi Asada and Gerald R Galluppi, contributing to the advancement of pharmaceutical research and development.
Conclusion
Megumi Maruyama's work in modified release formulations exemplifies her dedication to improving therapeutic options for patients. Her innovative approach and collaborative spirit continue to drive advancements in the pharmaceutical field.